Life Sciences Blog

Whether you're in pharma, biotech, medical devices, or any other industry, our diverse services and expert guidance are designed to keep you informed and ahead of industry trends. Dive into our content and stay connected with the latest advancements and best practices.

Life Sciences Blog

Why-self-inspections-or-internal-audits-are-essential-for-your-QMS-1536x864
Circles_banner_news&events

Designing Meaningful Dissolution Tests: Practical Foundations and Pharmaceutical Applications

EU MDR Bottleneck Ahead: Why 2026 Will Be a Defining Year for Medical Device Manufacturers

How to Integrate Outsourced QA into Your QMS (Without Losing Oversight)

Validating Single-Use Systems in Biopharma: Key Requirements and Emerging Expectations

The Evolution and Importance of Dissolution Testing in Pharma

European Pharmacopoeia Chapter 2.4.35 on Extractable Elements in Plastics for Pharmaceutical Use

Validating Your QMS: What Pharma Professionals Need to Know

The Critical Role of the CH-REP in Swiss Market Access

The UK Responsible Person (UKRP): Your Official Representative and First Step into the UK Market

How to Prepare a Submission-Ready Environmental Risk Assessment (ERA)

Your Gateway to the EU Market: The Crucial Role of the Authorised Representative

Inside the EudraLex Annex 22: What’s New for AI in Pharma Manufacturing and Why These Revisions Matter

Analytical Method Validation: From One-Time Event to Lifecycle Approach

Usability Testing and MDR: Managing Risk with the Human Factor

Enabling Pharmacovigilance Scale: The Role of Data, Systems, and People

Environmental Risk Assessments (ERA) in Pharma: Balancing Health & Environment

Boosting Compliance and Efficiency: How External Expertise Strengthens APR/PQR Compliance

In-Silico Testing & MDR: Smarter Evidence, Not Optional Evidence

MDSW for Startups: A Practical Guide to Compliant Medical Software Development

Bridging the Regulatory Gap: Integrating IVDs into Global Clinical Trials

IVD Use in EU Clinical Trials: Key Considerations Under the IVDR

Toxicological Assessment of Extractables and Leachables (E&L)

Scale Smart: Choosing the Right Pharmacovigilance Operating Model for EU Growth

The Eyes of High-Performance Liquid Chromatography (HPLC): Strategic Use of Detectors in Drug Development and Quality Control

Life Sciences Digitization: Your Compliance Roadmap

QMSR for Startups: What to Do Before February 2, 2026

Environmental Risk Assessment (ERA) in Drug Products: Understanding the EMA Guideline

Local Pharmacovigilance Matters: Where Global Strategy Meets On-the-Ground Reality

FDA Expands Unannounced Foreign Inspections: How to Stay Inspection Ready

MDR & Cybersecurity: What Your Technical File Needs to Prove

Eudralex Annex 11 Revision: What Pharma Companies Need to Know Before 2026

Commissioning & Qualification of Temperature-Controlled Storage Equipment in Pharma

Why Effective Project Governance Matters in Global Pharmacovigilance

Validating Your LIMS: A Strategic Guide to Compliance and Confidence

Annex XIV Applications: Avoid These 5 Common Delays

PMCF: How QbD Group Helps You Master MDR Compliance from Plan to Report

PMCF Surveys: Your Guide to MDR Compliance

Preparing for an Extractables and Leachables (E&L) Risk Evaluation: Key Topics to Consider

Nitrosamines Control: Real Lessons from Reporting Updates

TOC Measurement During Cleaning Validation: Practical Tips for Reliable Results

5 Smart Reasons to Outsource Your Stability Studies

AI Literacy Under the AI Act: Turning Compliance Into Opportunity

How to Perform Periodic Reviews of Computerised Systems

Pharma 4.0: The Next Leap in Pharmaceutical Innovation

Why a Strong Quality System Is Critical for Pharmacovigilance Success

Critical Findings in GMP Audits: How to Identify & Manage Them Effectively

Handling Medical Information Requests and Enquiries: A Scientific Services Guide

Outsourced QA: Benefits, Risks, and Long-Term Impact

IVDR Compliance for Large-Panel Next-Generation Sequencing (NGS) Devices: A Strategic Guide

The Triangle Dilemma of Quality, Cost & Time in GMP Laboratories

Pharmacovigilance Is a Shared Responsibility: Why Adverse Events Reporting Matters More Than Ever

Drowning in APR/PQR Work? Here’s How to Lighten the Load.

Patient Enrolment and Retention in Clinical Trials: How to Improve Recruitment and Keep Patients Engaged

Can IVDR Be Your Global Regulatory Compass for Market Entry?

Clinical Trial Site Selection and Qualification: A Practical Guide

How to Transform Pharmacovigilance into a Growth Strategy

The role of Good Distribution Practices (GDP) and Quality Risk Management (QRM) in ensuring pharmaceutical integrity

Risk Management in Clinical Trials: Assessment & Mitigation Strategies

eCTD Publishing: 10 Tips for a Smooth Submission Process

Contamination Control Strategy (CCS): a key requirement in the new Annex 1

Why do I still need to look at my QMS under the IVDR if it is ISO 13485 certified?

Vaccine Safety and Pharmacovigilance: ESAVI & EU Tools

IMPD Clinical Trials: key quality considerations for regulatory success

Cleaning Validation in Pharma: Strategy & Best Practices

Smarter audit planning and management in life sciences: stay compliant, save time

How Veterinary Pharmacovigilance Supports Global Health Through Audits

The New Rules for Monitoring Critical Medicines: Safeguarding Europe’s Medicine Supply

Why Extractables and Leachables Matter in Pharma Risk Assessments

GMP Annex 21: key requirements for importing medicines into the EU

Sub-visible particles in pharmaceutical products: understanding EP General Chapter 2.9.19

Analytical Method Transfer under GMP: tips & pitfalls

How QPs Verify GMP Compliance for Non-EU Manufactured Products

Analytical Method Transfer: a practical step-by-step guide to compliance and efficiency

ICP-MS vs ICP-OES analysis: choosing the right elemental impurity testing method

Establishing and Maintaining the Right Level of Clinical Evidence under the EU IVDR

Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) under the MDR: Ensuring safety and performance

EU-QPPV registration and local pharmacovigilance contacts: what you need to know

Pharmacovigilance Agreements (PVA) simplified: key requirements and best practices for compliance

Container Closure Integrity Testing (CCIT): why it’s essential for pharmaceutical packaging

Quality Audits Management: Quality Audits managed according to QMS 

Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights 

Operational software compliance that adds value: essential pharma Q&A

Operational software compliance in pharma: a practical guide

Essential steps for pharma software compliance in the operational phase

How to avoid non-compliance in the pharmaceutical industry

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

What are the requirements for IVD Clinical Performance Studies Under IVDR and ISO 20916?

5 Key Toxicological Monitoring Tests for Regulatory Compliance

Pharmacovigilance (PV) Safety Databases: Why They Matter and How to Choose the Right One

How to define your Clinical Performance Strategy?

Understanding REACH Registration for Chemicals in Pharma

Why is Clinical Performance key to a successful IVDR submission?

Sterilization Validation: A Practical Guide to Ensuring Safety and Compliance

15 Years of ATMPs – Reflecting on the Past, Shaping the Future

Maintaining Validation Excellence: Continuous Improvement Through Periodic Validation Reviews in Pharma

Technovigilance in Action: Safeguarding Health with Post-Market Surveillance of Medical Devices

Why Combining Scripted and Unscripted Testing Boosts Your CSV Strategy

The Rise of Knowledge Process Outsourcing in Drug Safety: Smarter Outsourcing for Safer Healthcare

Stay Ahead of Compliance: How to Effectively Manage Your Yearly Audits

Mastering EU Product Information: The Role of the EMA’s Linguistic Review Process in Centralised Procedures

Accurate but appealing: How our scientific copywriters and designers collaborate to create captivating content

Outsourcing Internal Audits: Benefits and Process Optimization in Your Pharma Company

Why scientists turn to communication: unlocking benefits for Life Sciences companies 

The Risk of Benzene Contamination in Drug Products: What Manufacturers Need to Know

Friability and disintegration for oral solid dose forms: the forgotten tests

Analysing MHRA Performance: Clinical Trial and Amendment Applications in the UK

Article 31 Referrals in Pharmacovigilance: A Brief Overview

How to Assess and Improve the Readability of Medicines: A Complete Guide | QbD Group

The Journey from Science to Story

Analytical Method Transfer: Common Pitfalls and How to Avoid Them

Elevate Pharma Imports with EU GMP Annexes 16 and 21

The Holy Grail: Achieving Inspection Readiness

Implementing PIC/S Standards in Hospital Cleanrooms: From Regulation to Application

Curb Your Enthusiasm – How to Avoid Rushing into Your Business Development Efforts with Unexpected Cost Consequences

The Role of Artificial Intelligence (AI) in Pharmacovigilance in Europe: Advances and Legislation

In-House Devices (IHDs): The Impact of IVDR, ISO 15189:2022’s Update, and MDCG 2023-1 in the EU

Social Media in Pharmacovigilance: Harnessing Online Conversations for Drug Safety

What to expect when being inspected?

SCADA Automation in Pharma: Boosting Efficiency and Compliance

Post-Market Success under IVDR: Prioritizing PMS & PMPF

Impact of PDE values on cleaning validation design in pharmaceutical manufacturing

Safeguarding Drugs: Controlling Elemental Impurities (ICH Q3D)

The Crucial Role of Clinical Evidence in IVDR Compliance

Regulatory Inspection Readiness: A Proactive Approach to CAPA and Compliance

Why start building IVDR-compliant Technical Documentation now? 

Understanding the European Commission’s proposal for extending the transitional period for IVDs | QbD Group

Drug-Device Combination Products and Article 117: How to Stay Compliant?

FDA’s QMSR Introduction: Aligning Device CGMP Regulations with ISO 13485:2016

Patient Support Programs: Enhancing Patient Care through Pharmacovigilance

IVDR Transitional Extension: Why full speed ahead is still the best strategy

A Deeper Dive into the MHRA Good Pharmacovigilance Practice (GPvP) Inspection Metrics and Findings

Declaration of Equivalence for Medical Devices under the MDR

Impact of the AI Act on the MedTech and Life Sciences Industry

The Impact of EU IVDR on Clinical Trials

MHRA to Launch RegulatoryConnect Portal in the UK: A New Era in Regulatory Management 

ICH Q2(R2) Validation of Analytical Procedures: An Overview of the Revised Guideline

How to create a GMP-Compliant Stability Protocol?

Digital Therapeutics in the UK: The Post-Brexit Landscape

Exploring the U.S. Regulatory Framework for Mobile Health

Toxicology Challenges in Pharma: How to Address Them?

Mobile Health Ascending and the WHO’s Global Strategy on Digital Health

MDR Certification for Legacy Devices: Integrating Clinical Evidence for Compliance

Digital Therapeutics (DTx) in Germany: Pioneering “Deutsche Gründlichkeit” with Quality by Design

The DTx Landscape in Belgium, France, and Their Inspiration from the German Model

Pharmacovigilance (PV) Audits: importance, process, and challenges

Quality and Regulatory Affairs: Key Elements of a Robust QMS in Pharma for Compliance and Success

The Rise of Mobile Health: Taking a Closer Look at the EU Regulatory Landscape

Continuous manufacturing in the pharmaceutical industry: enhancing drug production

Anticipate the Notified Body Rush: Ensure Timely MDR Compliance

MHRA’s International Recognition Procedure Post Brexit: Navigating Medicinal Product Registration in the UK

Understanding Software Medical Devices: Navigating the EU Regulations and Clinical Evaluations

CE approval for Medical Devices under MDR: key requirements for your device class

Qualifying a new GMP facility: from pitfalls to best practices

Navigating Project Complexities: QbD’s Project Management Process for Qualification and Validation Projects

Importing medicinal products into the EU? A brief guide to EU GMP compliance.

Computer Software Assurance (CSA) in Pharma Industry: First Steps to move from CSV to CSA 

Understanding plasmids: small molecules with big implications

Oncolytic viruses: the use for cancer immunotherapy

Paperless Validation in Pharma: embrace the future

GMP-compliant design of climate or stability chambers: the key to ensuring product integrity

4 Factors Influencing the Stability of Medicinal Products

State Of The Art Literature Review – Process and Documentation

Digital health in pharma: revolutionizing the industry from R&D to patient care

Mastering Cleanroom Qualification: navigating the latest regulatory updates 

Computerized System Validation in clinical trials: key considerations

State of the Art (SOTA) Literature Review – What, Why, When, and Who?   

The Importance of Stability Testing in Pharmaceutical Development

Pharma 4.0: The Future of Pharmaceutical Manufacturing

Clinical Literature Review – Common Gaps and Hurdles to Take

EudraLex Volume 4 Annex 11: compliance checklist and future prospects

A Deep Dive into Clinical Trials Regulations: Shifts and Strategies in the UK and EU

Status of the medical device regulatory landscape: An interview between QBD Group and Irdeto

The EU Commission Proposes a General Reform of Pharmaceutical Legislation – What it Means for Patients and the Industry

MDR transition: how to plan MDR compliance for your Medical Device?

Types of Medical Writing: Introduction to the Art of Medical Writing in Healthcare

Automated software testing for the GxP world

Analytical Method Validation: are your analytical methods suitable for intended use?

ILAP: Introduction to the UK’s Innovative Licensing and Access Pathway

MHRA GMDP Symposium: key insights, trends, and best practices

What is the Agile model in Computerized System Validation? 

EU GMP Annex 1 Revision: Manufacture of Sterile Medicinal Products – Summary and first insights

MDR Annex XVI: products with non-medical purpose — Compliance and Common Specifications (CS) 

UK’s medicines regulator announces IT roadmap

7 key areas to focus on during internal or supplier audits 

8 steps to successfully respond to non-conformities in an inspection report  

Introduction to Digital Health in Clinical Trials

What is the GAMP 5 V-model in Computerized System Validation? 

Essential Documents in Clinical Investigations with Medical Devices: a brief overview

UDI for software: how to mark your MDSW with a UDI?

The European Parliament adopts proposed amendment to Medical Devices Regulation 2017/745 (MDR) to extend transitional deadlines for legacy Medical Devices 

Qualification of laboratory equipment: key considerations and challenges

Back to Blog Are systems in compliance with ISO 80002-2 if we follow the guidelines described in GAMP5?

Change Control Management: how to keep your systems compliant?

The Advent of Artificial Intelligence and Machine Learning in Medical Devices

Medical Device development: the importance of Design Transfer and Process Validation

Annual Product Quality Review (APQR / PQR) in Pharma: importance, benefits & challenges

What is digital health? Exploring the landscape and future opportunities.

21 CFR Part 11 compliance checklist: does your system comply?

Team up with a Contract Research Organization (CRO) dedicated to medical devices to boost your clinical research strategy

Finding your way through the maze of international, European, and harmonized standards for medical devices

AI and machine learning validation: strategies and examples

The importance of high-quality gas distribution networks for critical process gases, even in the early development phase

GAMP 5 guide 2nd edition: what’s new?

Why self-inspections or internal audits are essential for your QMS

The regulatory pathway for your custom-made medical device

Medicine advertising in Belgium: a brief regulatory overview

PRRC under MDR and IVDR: meaning, requirements, and responsibilities

6 common myths about life sciences consultancy

Compressed gases in pharmaceutical manufacturing: best practices in microbial monitoring

Data migration in CSV: definition, purpose, and best practices

What is decommissioning in CSV?

Clinical Evaluation Report (CER): a must-have for all medical device classifications

Clinical Evaluation Plan (CEP): roadmap of the clinical evaluation strategy 

How to use electronic signatures in regulated industries?

EDQM and the CEP of the future 

CAR-T cell therapy: main components, manufacturing, and prospects

What is EUDAMED and what new requirements should medical device companies take into account?

GAMP categories for computerized systems: what are they and what are they for?

3D printing medical devices: enabling patient-specific solutions for a better quality of care

Dendritic (DC) cells: effective sentinels for immunotherapies

Natural Killer (NK) cells: a major breakthrough in the field of ATMPs

From IVDD to IVDR: avoid these pitfalls to get your CE marking in time

Medical device combination products: what regulations should you apply before marketing them in the EU?

IVDR classification of in-vitro diagnostic medical devices: a brief guide for manufacturers

MDR impact on MDSW: what has changed from MDD?

Medical Device Industry Trends: on wearables, AI, POC testing, IoT, and more

Unraveling Artificial Intelligence in Medical Devices: what do we know so far?

SaMD versus MDSW: what’s the difference between Software as a Medical Device and Medical Device SoftWare?

5 consequences of Brexit when selling medical devices in the UK

ATMPs: translating the expertise into a GMP process

What is a medical device? Key definitions and regulations around the world.

Why Medical Device Risk Management is as complex as it is crucial

Clinical Trials for ATMPs: which challenges to overcome?

10 things you should know before validating Computerized Systems

Smart factories: How digital twins can strongly improve your ATMP manufacturing processes

From idea to post market surveillance: the phases of the medical device lifecycle

Why QP challenges in ATMPs are different & what you need to know

How do you reduce the Cost of Goods, which is key to affordable ATMPs?

What you need to know to make your medical device UDI-ready in time

The key role of Regulatory Affairs in the pharmaceutical industry: from development to commercialization

Post-Market Surveillance of Medical Devices

Is your ATMP platform robust enough to deal with material input variability?

Quality by design methodology for the pharmaceutical industry

Automation Pyramid – FAQ

ATMP manufacturing for the market: main hurdles to be tackled to ensure a high-quality end product.

Anything you need to know about ATMPs: FAQ

ATMPs in a nutshell: what you should know about classification, quality and go to market

Artificial Intelligence in Advanced Therapy Medicinal Products

Market release of vaccines: European Union versus the United States of America

Technical Writing in Pharma and Biotech: Essential Tips

Serialization in the EU can become a competitive advantage if you dare to innovate

EU GMP Annex I: Are we ready for the challenges posed after its revision?

Pioneering with Artificial Intelligence to make personalized cell therapy more accessible

Updating Good Clinical Practice E6(R2)

Preparing for growing challenges in pharmaceutical serialization

Antleron & QbD team up to create a landslide in healthcare

Data integrity in the pharma industry – a short introduction

data-not-found No Items Found! Please Try Some Different Keywords
circle news